Navigation Links
Commercial Medical and Pharmacy Benefit Enrollment Down in New York
Date:6/17/2009

HealthLeaders-InterStudy's Managed Market Surveyor-Rx Evaluates How Medical and Pharmacy Lives are Covered at National, State and MSA Levels

NASHVILLE, Tenn., June 17 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that medical and pharmacy benefit enrollment in New York state declined between July 2008 and January 2009. According to data available in the newest release of Managed Market Surveyor-Rx, medical benefit enrollment declined 2.7 percent throughout the state (approximately 340,000 lives), while pharmacy benefit enrollment declined 3.6 percent (approximately 335,000 lives).

"The economy plays a large role in the enrollment declines seen in New York, particularly as the number of unemployed in the state nearly doubled in 2008," said Rebecca Waller, senior health plan analyst with HealthLeaders-InterStudy. "Overall, enrollment has decreased in New York at a higher rate than most other states."

In some states, insurers are able to retain some business lost through layoffs and business closures with sales to the individual market, but that sector is less of a factor in New York. State rules regarding medical underwriting make prices for individual designs relatively high.

The shifts seen in the New York market are just one example of the data available in Managed Market Surveyor-Rx.

"Managed Market Surveyor-Rx allows users to identify managed care enrollment trends across plans, plan type and geography to better inform resource deployment," said Russell Workman, principal director of data operations for HealthLeaders-InterStudy. "For pharmaceutical companies contracting with plans operating in New York, and throughout the country, our database provides a comprehensive assessment of a plan's market share by metropolitan statistical area (MSA) and its capacity in that market."

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. Study Shows Increases in Working After 65 and Using Commercial Insurance
3. Commercial Pharmacy Benefit Enrollment Experiencing Greater Shifts in Florida than Commercial Medical Benefit Enrollment
4. Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System
5. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
6. ProSolv Version 4.0.2 Makes Commercial Debut at ASE
7. moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico
8. Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
9. BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
10. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
11. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: